Gene Therapy

Global Gene Therapy Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 644 | Number of pages: 198 | Publish Date: Jul 2019 | Category: Lifesciences and Healthcare
Global Gene therapy market is valued at USD 0.67 Billion in 2018 and expected to reach USD 5.18 Billion by 2025 with the CAGR of 33.9 % over the forecast period. Increasing prevalence of the cardiovascular disease, cancer, genetic disorder, and painful existing treatment procedure is further driving Gene therapy market.

Scope of Gene therapy market Report:

Gene Therapy is associated with the experimental technique that uses genes to treat or prevent disease. In the future, this system could permit doctors to treat a condition by inserting a gene into patient’s cells rather than exploitation medication or surgery. Gene therapy replaces a faulty gene or adds a new gene in an attempt to cure disease or improve body's ability to fight disease. Gene therapy holds potential for treating a wide range of diseases, such as cancer, cystic fibrosis, heart disease, diabetes, hemophilia and AIDS. For example, suppose a brain tumor is forming by rapidly isolating cancer cells. Global gene therapy market report is segmented on the basis of Therapy type, Vector Type, application, and regional& country level. Based upon Therapy type, gene therapy market is classified as somatic and germline. Based upon Vector type Gene Therapy Market is classified into non-viral vectors and viral vectors. Based upon Application Gene therapy market is classified into Cancer Diseases, Monogenic Diseases, Infectious Diseases, Cardiovascular Diseases, Others. The regions covered in this Global Gene therapy market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Gene therapy is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Key Players for Global Gene therapy Market Reports– Global Gene therapy market Report covers prominent players are like Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical, Advantagene. Increasing prevalence of cardiovascular disease, cancer, genetic disorder, and painful existing treatment procedure is expected to grow Gene therapy market. Growing prevalence of cardiovascular disease, cancer, genetic disorder, and painful existing treatment procedure coupled with the increasing application of public health and clinical facilities is expected to drive Gene therapy market. As this therapy is transforming the current approaches to promote the excellence in health and prevent from cardiovascular diseases such as cancer and diabetes. In 2017, it is projected that around 14% (more than 34 million adults) were current smokers. While People with diabetes comprise 8.8% of the world’s population and IDF predicted that the number of cases of diabetes will rise to 642 million by 2040. In low-income countries, mainly in Africa, the older population faces a considerable burden of both non-communicable and communicable diseases. High cost of gene therapy treatment and unwanted immune responses such factors hindering the growth of gene therapy market. Technological Advancements leading to provide better technological procedures is the lucrative opportunity for gene therapy market in forecast period. Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Gene Therapy Market. Key Benefits for Gene Therapy Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape.

Gene Therapy Market Segmentation:

By Disease Indication • Cancer • Genetic disorders • Cardiovascular diseases • Ophthalmology • Neurological conditions • Others By Type of Vectors • Viral vectors • Non-viral vectors By Type of Cells • Somatic cells • Germline cells By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa North America is dominating the Gene therapy Market North America is dominating the gene therapy market during the forecast period due to increasing healthcare expenditure coupled with advancement of technologies. The majority of gene therapies clinical trials recognized targeted cancer diseases. In the US, around 66.81% of gene therapy clinical trials are carried out. While all other countries participated in a small percentage of the trials such as 9.45% in the UK, 3.95% in Germany and around 2% each in Switzerland, France, China, and Japan. Globally, regeneration medicine companies providing Gene cell therapy and tissue engineering for therapeutic developers is expected to grow gene therapy market in this region. Gene Therapy Market Key Players: • Pfizer Inc. • Novartis AG • Bayer AG • Sanofi • GlaxoSmithKline plc. • Amgen Inc. • Boehringer Ingelheim International GmbH • uniQure N.V. • bluebird bio, Inc. • Celgene Corporation • Others This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content

1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Gene Therapy Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Gene Therapy Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Gene Therapy Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Gene Therapy Market Overview: Quantitative Analysis
3.1. Global Gene Therapy Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Gene Therapy Market Revenue Market Share (%), 2014- 2025
3.3. Global Gene Therapy Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Gene Therapy Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Gene Therapy Market Analysis: By Disease Indication
5. Chapter – Global Gene Therapy Market Analysis: By Type of Vectors
6. Chapter – Global Gene Therapy Market Analysis: By Type of Cells
7. Chapter - Global Gene Therapy Market Analysis: By Manufacture
7.1. Global Gene Therapy Market Revenue (USD Million), by Manufacturer, 2014 - 2025
7.2. Global Gene Therapy Market Share (%), by Manufacturer, 2018
7.3. Global Gene Therapy Market Sales (Number of Units), by Manufacturer, 2014 - 2025
7.4. Global Gene Therapy Market Share (%), by Manufacturer, 2018
7.5. Global Gene Therapy Market Price (USD/Unit), by Manufacturer, 2014 - 2025
7.6. Global Gene Therapy Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
7.7. Merger & Acquisition
7.8. Collaborations and Partnership
7.9. New Product Launch
8. Chapter –Gene Therapy Market: Regional Analysis
8.1. North America
8.1.1. North America Gene Therapy Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
8.1.2. North America Gene Therapy Market Revenue (USD Million) By Country, 2014 – 2025.
8.1.3. North America Gene Therapy Revenue Market Share (%) By Country, 2014 – 2025.
8.1.4. North America Gene Therapy Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.5. North America Gene Therapy Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.6. North America Gene Therapy Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
8.1.7. North America Gene Therapy Market Sales (Number of Units) By Country, 2014 – 2025.
8.1.8. North America Gene Therapy Sales Market Share (%) By Country, 2014 – 2025.
8.1.9. North America Gene Therapy Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.1.10. North America Gene Therapy Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Chapter - Company Profiles
9.1. Pfizer Inc.
9.1.1. Financials
9.1.2. Product portfolio
9.1.3. Gene Therapy Market Revenue (USD Million) and Market Share (%), 2014 - 2018
9.1.4. Gene Therapy Sales Market Share (%), 2014 - 2018
9.1.5. Business strategy
9.1.6. Recent developments
9.2. Pfizer Inc.
9.3. Novartis AG
9.4. Bayer AG
9.5. Sanofi
9.6. GlaxoSmithKline plc.
9.7. Amgen Inc.
9.8. Boehringer Ingelheim International GmbH
9.9. uniQure N.V.
9.10. bluebird bio, Inc.
9.11. Celgene Corporation
9.12. Others
 
10. Chapter – Market Research and Findings